Economic Evaluation of Direct Acting Antiviral (DAA) Treatments for Hepatitis C Virus (HCV) Infection in Previously Treated Patients from the Peruvian Health Care System Perspective
Abstract
Authors
J.G. Ariza R. Hinojosa